Atrial fibrillation (AF) is the most common arrhythmia worldwide. The estimated prevalence is lower in women (373 per 100,000) than in men (596 per 100,000) 1 . The true prevalence is likely to be substantially higher given that many individuals remain undiagnosed 2 . As the popu lation ages, the prevalence and costs of AF are expected to increase.
, than in men. We review reports on sex-specific differences in the incidence, prevalence, risk factors, genetics, and pathophysiology of AF, and in the clinical presentation and prognosis of women and men with the arrhythmia (FIG. 1) . We underscore the many remaining unanswered questions in sex-specific differences in AF for future studies to address. A deeper knowledge of the variation by sex of risk factors and complications for AF might aid the development of novel measures to prevent and manage the arrhythmia.
Epidemiology

Incidence, prevalence, and lifetime risk
In North American and European populations, the age-adjusted incidence of AF has been estimated to be 1.5-2.0-fold higher in men than in women (see Supplementary information S1 and S2 (tables)). The Framingham Heart Study 5 and the Olmstead County, Minnesota study 16 have reported the AF incidence (per 1,000 person-years) in women to be 1.6 and 2.7, respectively, compared with 3.8 and 4.7 in men. The lower incidence of AF among women seems to be consistently observed outside North America and Europe, although fewer studies are available 1, 17 . AF incidence has been shown to increase disproportionately with increasing age in both women and men, reaching as high as 30.4 per 1,000 person-years in women and 32.9 per 1,000 person-years in men by age 85-89 years 18 .
Similarly to incidence, age-adjusted prevalence of AF has been reported to be lower in women than in men in North America and Europe (FIG. 2;  see Supplementary information S3 and S4 (tables)). A large, retrospective study of older adult (aged ≥65 years) US Medicare recipients in 2007 reported the prevalence of AF to be 7.4% in women and 10.3% in men Study 5 showed similar results; the age-adjusted period prevalence (per 1,000 person-years) during 1998-2007 was 49 . 4 in women compared with 96.2 in men. In addition, a community-based, randomized, controlled trial in Sweden, in which individuals aged 75-76 years were enrolled for AF screening, showed a lower prevalence of this arrhythmia in women than in men (9.2% versus 15.0%) 20 . Because women typically live longer than men, the absolute number of women with AF exceeds the number of men with AF in Medicare data 19 . The overall prevalence of AF varies by ancestry; prevalence studies of Asian populations have been less consistent than those of North American and European poulations. Two large, cross-sectional studies of Chinese cohorts reported that age-adjusted prevalence of AF was similar in women and men (0.76% versus 0.78%, and 0.63% versus 0.66%) 21, 22 , whereas data from Singapore indicated that prevalence was lower in women than in men (0.6% versus 2.6%) 23 . Other East Asian studies also have reported lower prevalence of AF in women than in men; however, the results are not directly comparable owing to lack of age-adjustment 17, [24] [25] [26] [27] .
Multiple studies have evaluated secular trends in the sex-specific incidence and prevalence of AF. In the Olmstead County, Minnesota study 16 , a trend towards increased incidence in both women and men from 1980 to 2000 was noted, but no significant sex-specific difference was observed in the rate of increase. In a community-based study in Iceland, a trend towards increasing incidence for women, but not for men, was found during the follow-up period 1991-2008 (REF. 28 ). The Framingham Heart Study 5 investigators reported that AF incidence increased during the 50-year period from 1958 to 2007 in both women and men. The trend for increased AF incidence has been shown to correspond to the higher prevalence of AF over the years for both women and men in various population settings 5, 19, 28, 29 .
In North American populations, despite higher incidence of AF in men, lifetime risks of AF in women and men were similar owing to longer life expectancy for women. In the Framingham Heart Study 30 , the lifetime risks of AF in women and men at age 60 years were 23.4% and 25.8%, respectively. In the Rotterdam Study 31 , the lifetime risks for women and men at age 55 years were 22.2% and 23.8%, respectively. A population-based study from China showed similar lifetime risk for women at age 55 years (22.2%); however, in contrast to North American populations, this lifetime risk for women in China was higher than that for men (16.7%) 32 .
Risk factors
Most studies have reported a higher incidence of AF in men than in women. However, after adjusting for height and other AF risk factors, a multivariable risk score for incident AF in a three-cohort study showed male sex was no longer significantly associated with AF 33 . The study findings indicated that part of the increased risk of AF observed in men was related to body size. Epidemiological studies worldwide have described several major risk factors associated with AF in both women and men, including older age, higher BMI and blood pressure, hypertension treatment, diabetes, valvular heart disease, HF, and myocardial infarction (MI) 4, 5, 34 . Advancing age is the most important risk factor, leading to about a doubling in AF incidence with every 10-year increase in age 4 . However, in studies from Australia 10 , Europe 35, 36 , and North America 5 , women with AF are, on average, older than men. In the Framingham Heart Study 5 between 1998 and 2007, 74% of women with AF were aged ≥70 years, compared with 58% of men.
Over the past 50 years, the prevalence of major risk factors has changed in both women and men with AF 5 . In particular, BMI has increased significantly 5 (FIG. 3) .
In the Women's Health Study 3 , the population attributable risk of AF with increased BMI during the 12 years of follow-up was 18.3%. BMI combined with systolic blood pressure or hypertension conferred the highest risk of AF in both sexes 3, 37, 38 . Women with AF have a higher prevalence of hypertension and valvular heart disease and a lower prevalence of coronary heart disease than men with AF 5, 10, 35 . Consistent with these findings, the
• Women generally have lower age-adjusted incidence and prevalence of atrial fibrillation (AF) than men; however, given the greater longevity of women, the absolute number of men and women with AF is similar • The prevalence of major risk factors differ by sex; women have higher prevalence of hypertension and valvular heart disease, and lower prevalence of coronary heart disease, than men • Women are more likely to present with atypical symptoms, such as weakness and fatigue, have longer duration of symptoms, and report worse quality of life and more-frequent depression than men • Female sex has been shown to be a risk factor for AF-related stroke or thromboembolism, myocardial infarction, and mortality, but has not been associated with incident heart failure or dementia • Future research is needed to address the knowledge gaps in sex-specific differences in AF population-attributable risk of coronary heart disease was higher for men than women in the Framingham Heart Study 4 , and the population-attributable risk of valvular heart disease was lower. Over the past 50 years, the prevalence of valvular heart disease in women with AF has decreased and become a less important risk factor in high-income countries 5 . Globally, however, the prevalence of valvular heart disease among individuals with AF is still >25% 39, 40 , largely caused by the higher incidence of rheumatic heart disease in low-income and middle-income countries. The differences in risk factors for AF between women and men in low-income and middle-income countries have been inadequately defined and require further investigation.
A variety of other risk factors have been associated with AF, including alcohol intake 41 , physical activity 42 , hyperthyroidism 43 , and inflammatory pathways 44 ; however, sex-specific differences have not been consistently demonstrated for these risk factors. The relation ship between physical activity and AF seems to be complicated. In men, a U-shaped association has been reported, in which sedentary lifestyle and vigorous exercise are both associated with increased risk of AF 42, 45, 46 , whereas moderate activity is protective 47 . In women, vigorous exercise has not been shown to increase AF risk, although moderate exercise is associated with a lower risk of AF than sedentary lifestyle 48, 49 . In the Women's Health Initiative 49 and the Swedish Mammography Cohort 50 -two studies involving only womenleisure-time physical activity was associated with a lower risk of AF.
Genetics
Several studies to evaluate familial aggregation of AF have reported substantially increased risk of AF in individ uals with affected family members 8, 9, [51] [52] [53] [54] [55] [56] . The evidence for a differential risk of AF dependent on the sex of the affected family member is more ambiguous (see Supplementary information S5 (table)). In a large register study including >300,000 Swedish individ uals with AF or atrial flutter, the investigators reported increased risk of AF in mothers (OR 2.02, 95% CI 1.95-2.09) of patients with AF or atrial flutter compared with fathers (OR 1.85, 95% CI 1.79-1.91) 9 . Likewise, mothers of female patients and women with at least two affected siblings seemed to have higher risks of AF than their male counterparts 9 . No formal tests of sex-specific differences were performed, but the confidence intervals were not overlapping, consistent with a significant difference. In another large register study evaluating familial risks of lone AF in Denmark, men with one first-degree relative with lone AF were shown to have increased risk of lone AF compared with women (male/female ratio 1.37, 95% CI 1.02-1.82); however, whether this finding reflects the increased baseline risk of lone AF in men is unclear 8 . In a group of 192 patients from North America with lone AF, Chen and colleagues reported that more women than men had confirmed familial lone AF (at least one first-degree or seconddegree relative with documented lone AF; 31.7% versus 13.9%; P = 0.03); however, the sample size was quite small 52 . Other studies have reported sex-stratified familial risks of AF, but no significant differences have been demonstrated [53] [54] [55] [56] [57] . Although studies indicate that AF might be sexually dimorphic, the molecular genetic basis of variation between the sexes has received little attention. In 2005, Ravn et al. discovered a genetic variant in the X-linked gene KCNE5 that was more frequent in 96 controls than in 158 patients with AF, and that was found to be protective against AF 58 . Given that women have two copies of the X chromosome whereas men have one, the investigators suggested that the variant might contribute to the lower prevalence of AF in women. A similar report from Karst et al. in 2010 identified a deletion in the X-linked gene EMD in a multigenerational family with progressive sinus node dysfunction and AF 59 . Several recent studies have investigated whether common genetic variants identify individuals at higher risk of AF. None of the genetic risk scores developed thus far has reported sex-specific differences in AF prediction. Pathophysiology AF is thought to develop through ectopic focal triggering or re-entry mechanisms [60] [61] [62] . Electrophysiology studies have demonstrated that electrical heterogeneity within the atria is associated with differences in Ca 2+ and K + handling and, therefore, resting membrane potential, refractory period, and action potential duration [63] [64] [65] [66] . Ectopic triggering activity most commonly originates from the sleeves of myocardial tissue that extend into the pulmonary veins from the left atrium. The propensity for triggered activity in the pulmonary myocardial sleeves might be related to the shorter action potential duration, lower resting membrane potentials, and nonuniformity in myofibril arrangement 7, 62, 67 . Structural changes in the atria are also associated with the initiation and mainten ance of AF, including fibrosis 68 and dilatation [69] [70] [71] . After initiation of AF, the arrhythmia itself is associated with both electrical [72] [73] [74] [75] and structural remodelling 68, 76, 77 that promotes its maintenance and can increase the burden of AF. The number of studies investi gating sexrelated differences in the pathophysiology under lying AF (FIG. 4) are limited, and the mechanisms remain inadequately understood.
Structural properties
Larger left atria and increased left ventricular wall thickness have been associated with increased risk of AF 71 and, therefore, cardiac structural differences between women and men might help to explain the lower prevalence of AF among women. Women generally have reduced ventricular wall thickness and smaller left atria and ventricles compared with men [78] [79] [80] [81] . However, in a small study of women referred for cardiac MRI, more atrial fibrosis was detected using delayed-enhancement MRI in women than in men 82 . The plasma concentrations of the inflammatory marker C-reactive protein 83 and of fibroblast growth factor-23 (REF. 84 ) have been found to be higher in women than in men in epidemio logical studies. Both factors have been associated with increased risk of AF and might contribute to increased atrial fibrosis in women 84, 85 . Fibroblast growth factor-23 has also been associated with increased risk of cardio embolic stroke, but not other stroke types 86 . How the increased risk of AF associ ated with atrial fibrosis interacts with other risk factors that confer a lower incidence of AF among women is uncertain.
Electrical properties
A number of electrical differences have been noted between women and men. In a rabbit model, left atrial and pulmonary vein tissue from female animals had a longer action potential duration, and pulmonary vein tissue had a more negative resting membrane potential, than that from male animals 87 . In one study of patients undergoing catheter ablation for AF, women required more-extensive ablation of nonpulmonary vein foci than men 88 , suggesting that patterns of electrical heterogeneity vary by sex. 
Hormones
Potential contributions of sex hormones to electrophysiological properties have been explored in a few studies. Progesterone has been associated with shortened action potential 89, 90 and QT interval during the luteal phase of menstrual cycle 91 ; however, its role in the pathogenesis of AF in women remains unclear. Of particular interest is the role of oestrogen in modulating electrophysiological properties in women. In one study, women with a history of paroxysmal supraventricular tachycardia were found to experience significantly higher incidence and longer duration of episodes during the luteal phase than in the follicular phase of the menustrual cycle 92 . In the same study, an inverse correlation between serum oestro gen concentration and the number and duration of supraventricular tachycardia episodes was noted. In postmenopausal women, acute administration of oestradiol prolongs right intra-atrial and atrioventricular nodal conduction time, and right atrial effective refractory period 93 . The results have been replicated in a female mouse model, in which ovarectomy caused shorten ing of both PR interval and the conduction time from the right atrium to the atrioventricular node and bundle of His, whereas oestrogen replacement had the opposite effect 94 . Nevertheless, whether oestrogen has a direct role in the reduced incidence of AF in women compared with men remains uncertain, because most women develop AF at an older age, often after menopause. Hormone replacement therapy in postmeno pausal women does not seem to be associated with the risk of incident AF. In the Women's Health Initiative Study 95 , no difference was observed in the risk of incident AF between the group of postmenopausal women randomly assigned to oestrogen replacement only and the placebo group, after adjusting for incident coronary heart disease and HF. In addition, in rabbit models, oestradiol increased QT interval and decreased delayed rectifier potassium currents 96, 97 . Animal models are consistent with electrocardiogram (ECG) recordings from healthy individuals demonstrating that women have, on average, a longer QTc interval than men 98 . The link between QTc interval and risk of AF in women is probably complex. The Copenhagen ECG Study 99 , which included ECGs from almost 290,000 individuals, showed that the association between QTc interval and risk of developing AF is J-shaped, with both a shorter and a longer QTc interval being associated with increased risk of AF. PR interval has been shown to be shorter in women than in men 100 , but similarly to the findings for QTc interval, the Copenhagen ECG Study 99 showed that both long and short PR intervals were associ ated with increased risk of AF in women, whereas only longer PR intervals were associated with AF in men. Oestradiol also seems to modify calcium fluxes. In a rat model, oestradiol administration to heart slices led to increased calcium influx 101 , whereas in female guinea pigs, cytosolic calcium loading in response to hypoxia and reoxygenation was reduced in cardiomyocytes pretreated with oestradiol 102 . How the various physiological effects of oestradiol interact to modify the risk of AF in women is currently uncertain.
In men, lower testosterone levels have been associated with increased risk of AF. In the Framingham Heart Study 103 , one standard deviation decrease in testosterone level was associated with a hazard ratio of 3.53 (95% CI 1.69-6.37) in men aged ≥80 years in multivariableadjusted models. An experimental model with gonadectomized male mice demonstrated that testosterone deficiency increased atrial arrhythmogenicity, and that testosterone replacement attenuated the effect 104 . Whether sex hormones exert direct effects on atrial arrhythmogenesis or indirect effects by influencing the risk of cardiovascular diseases remains to be elucidated. Nature Reviews | Cardiology Higher risk of stroke in women with AF than in men with the arrhythmia has been extensively studied, and many putative mechanisms have been identified 105 . Female sex is also a risk factor for non-ST-segment elevation MI in individuals with AF; potential mechanisms include increased left ventricular wall thickness leading to subendocardial ischaemia and poorly controlled heart rate leading to demand ischaemia 106 . In addition, female sex is a well-known risk factor for HF with preserved ejection fraction, possibly attributable to haemo dynamic changes and cardiovascular remodelling after menopause 105, 107 . The reported literature suggests that sex-specific differences in hormones and in electrical and structural characteristics might help to explain variation in incidence, prevalence, burden, and complications associated with AF in women and men. As called for by the National Institutes of Health, preclinical studies will bene fit from more balance in female and male cellular and animal models 108 . More-detailed basic and clinical investigations are required to define the pathophysiological basis of sex-specific differences in AF.
Clinical presentation Classic symptoms of AF are palpitations, dyspnoea, dizziness, and chest pain 35, 109 . A systematic review of two randomized, controlled trials and four observational studies of AF published in 2015 reported that asymptomatic AF was less common among women than among men (relative risk [RR] 0.57, 95% CI 0.52-0.64) 12 . Women seem to be more likely to seek care for symptoms, which might be partly attributable to higher mean heart rates at presentation 10, 13 . In a study of patients visiting the emergency department, women were more likely to have longer duration of symptoms and to present with atypical symptoms, such as weakness and fatigue 10, 11 . The presence of atypical symptoms might contribute to the worse outcomes seen in women, because they might delay diagnosis and care. All the above factors might contribute to the worse quality of life 110 and more-frequent depression 10 experienced by women with AF than by men with AF. The first presentation of individuals with AF can be with stroke 11, 111 or cardiomyopathy 12, 35 . To our know ledge, variations by sex in the presentation with cardiomyopathy or stroke have not been reported. 
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Figure 4 | Potential sex-specific differences in pathophysiological mechanisms of atrial fibrillation (AF). The pathophysiological mechanisms that explain the sex-specific differences in AF incidence and associated complications have been incompletely studied. We present potential mechanisms identified on the basis of reported sex-specific differences in genetics, risk factors, hormones, electrical and structural properties, and other factors that might help to explain why women have a lower incidence and prevalence of AF, but have a higher risk of complications. AF causes electrical and structural remodelling that promotes AF, leading to the phrase 'AF begets AF'. Note that none of these interactions has been rigorously studied (see also 
Prognosis
Stroke and thromboembolism
Female sex is a well-recognized, independent risk factor for AF-related stroke 14 and systemic thrombo embolism [112] [113] [114] . The AHA/ACC/Heart Rhythm Society 60 , and a Canadian (HR 1.14, 95% CI 1.07-1. 22) 122 study, which all included a mixture of warfarin users and nonusers, reported higher risk of stroke in women than in men.
The link between female sex and stroke might vary between populations and age groups [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] . Whether female sex confers an additional risk in women aged <65 years without any other risk factors is unclear. The annual risk of stroke is estimated to be very low in women aged <65 years with 'lone' AF (that is, CHA 2 DS 2 -VASc = 1 with female sex as the only risk factor) 115, 133 , and the current European guidelines do not recommend anticoagulation therapy for this group 115 . Notably, a nationwide register study of >120,000 individuals with AF in Denmark found a rate of thromboembolism as high as 1.24 per 100 person-years among women aged <65 years with lone AF at 1-year follow-up 134 . By contrast, however, a Swedish nationwide study of >140,000 individuals with AF showed that the annual risk of stroke for women with AF who were aged <65 years was 0.1-0.2% 133 . Some studies suggest that female sex might be a substantial risk factor for AF only for those aged >75 years 117, 118 . Dementia AF has been implicated as a risk factor for dementia in several longitudinal studies [135] [136] [137] [138] [139] [140] [141] [142] . In 2015, investigators from the Rotterdam Study 135 reported that prevalent AF was associated with increased risk of dementia, when adjusting for stroke (HR 1.33, 95% CI 0.99-1.78). Very few studies have examined a possible interaction between sex and AF on the risk of dementia or cognitive impairment (see Supplementary information S7 (table)). All three studies identified through our search suggested that sex is not a significant modifier of dementia in individ uals with AF [136] [137] [138] . In the Olmsted County, Minnesota study 136 , no difference in the rate of dementia detection was observed between women and men with AF without a history of cognitive impairment or stroke. Similarly, a Taiwanese study that used a health insurance database showed that the risk of dementia was similar in women and men 137 .
Heart failure AF has been shown to be an independent risk factor for HF. The temporal association between AF and HF was evaluated in the Framingham Heart Study 143 ; among 539 participants with AF, the crude incidence of new-onset HF was 33 per 1,000 person-years during a mean follow-up of 5.6 years. In another study using a cohort from Olmsted County, Minnesota, the investigators found that among 3,288 participants with AF and no history of HF, the crude incidence of new-onset HF was 44 per 1,000 person-years during a mean follow-up of 6.1 years, with a cumulative incidence of nearly 20% within the first 5 years 144 .
Most of studies to evaluate sex-specific differences in the AF-related risk of HF have shown no significant difference; however, a few studies have suggested a higher risk in women (see Supplementary information S8 (table) ). In an analysis of 725 participants with AF in the Framingham Heart Study 145 , no significant difference was noted in the 10-year incidence of HF for women (4.30 per 100 person-years) and men (3.34 per 100 person-years). The study suggested that women had a higher incidence of HF with preserved ejection fraction than men, although the association was non significant 145 . A study from Groningen, the Netherlands found that AF is an independent risk factor for new-onset HF with preserved ejection fraction in women, but not in men 146 . A series of other studies have evaluated sex-specific differences in AF-related risk of HF, reporting negative results 35, [147] [148] [149] [150] [151] . The study from Olmsted County, Minnesota showed a reduced risk of HF with male sex (multivariable-adjusted HR 0.81, 95% CI 0.69-0.95) 144 . Additional studies into sex-specific differences in AF with reduced versus preserved systolic function are needed.
Myocardial infarction
Several studies have established an association between AF and risk of MI 106, [152] [153] [154] . The REGARDS study 152 showed that AF is associated with a twofold higher risk of MI among participants without a history of coronary heart disease, after adjusting for cardiovascular comorbid ities (such as diabetes, hypertension, chronic kidney disease, hyperlipidaemia, and history of stroke or peripheral vascular disease) and other therapies (such as anticoagulants). AF has also been shown to be a risk factor for MI in men with CHA 2 DS 2 -VASc = 0 and women with CHA 2 DS 2 -VASc = 1 (REF. 154 ).
Possible sex-specific differences in the risk of MI attributable to AF have been suggested (see Supplementary information S9 (table)). Data from the ARIC 106 and REGARDS 152 studies indicated that the associ ation between AF and MI was greater in women than in men.
, In the ARIC study 106 , the increased association between AF and MI in women was limited to non-ST-segment elevation MI. In a separate analysis 
Clinical presentations
Differences in presentation
Incorporate sex-specific differences in AF-related symptoms in population screening programmes; investigate implications of sex-specific differences in AF-related symptoms and outcomes
Stroke and thromboembolism
Underlying cause of the increased risk of stroke in women with AF Identify genetic, anatomical, physiological, and sociocultural risk factors associated with increased risk of AF-related stroke in women Differences in prognosis after AF-related stroke
Investigate sex-specific differences in short-term and long-term neurological deficits and mortality after AF-related stroke
Dementia
Differences in risk of dementia
Perform well-powered, longitudinal studies to investigate sex-specific differences in association between AF and cognitive impairment and dementia, independent of stroke Underlying cause of AF-related dementia
Identify sex-specific differences in anatomy and physiology associated with AF-related dementia, through studies on both women and men, and male and female animal models
Heart failure
Differences in risk of AF-related heart failure Investigate sex-specific differences in the incidence of AF-related heart failure with preserved or reduced ejection fraction
Underlying causes of increased risk of AF-related heart failure with preserved ejection fraction in women
Identify sex-specific differences in cardiac anatomy and physiology associated with AF-related heart failure subtypes, through studies on both women and men, and male and female animal models
Myocardial infarcion
Differences in risk of myocardial infarction
Conduct validation studies for sex-specific differences in the risk of AF-related myocardial infarction using different population settings Identify pathophysiological, genetic, clinical, social, and behavioural risk factors associated with increased risk of myocardial infarction subtypes in women and men with AF, testing for effect modification by sex
Mortality
Differences in mortality Conduct well-powered, longitudinal studies of whether sex-specific differences in mortality associated with AF vary by ethnicity or race and country Determine the mechanisms underlying sex-related differences in AF-associated mortality
Pathophysiology
Preclinical studies Balance female and male animal models in studying mechanisms of AF Sex-specific differences in electrical mechanisms
Identify sex-specific differences in atrial resting membrane potential, action potential duration, and refractory period Evaluate whether differences exist in triggered foci and re-entry mechanisms driving AF and location of origination between women and men Evaluate whether sex-specific differences exist in the electrical changes that occur after the development of AF that promote AF maintenance Sex-specific differences in structural mechanisms
Evaluate whether structural sex-specific differences exist before and after development of AF Hormone differences and risk of AF Perform longitudinal studies to evaluate the associations between hormonal differences and the risk of AF AF, atrial fibrillation.
of women and men with CHA 2 DS 2 -VASc scores of 0 and 1, respectively, the association between AF and MI was 1.5-fold higher in women than in men; however, the interaction was not significant 154 . Conversely, the Cardiovascular Health Study 153 of older adults has shown a significant sex interaction (P = 0.02) such that women with AF had a higher risk of coronary heart disease (HR 2.3) than their male counterparts (HR 1.6).
Mortality
In 1998, investigators from the Framingham Heart Study 15 established that AF was associated with increased mortality, when they reported a 1.5-fold increase in the risk of death in men and a corresponding 1.9-fold increase in women, adjusting for clinical risk factors. In the study from Olmsted County, Minnesota, new-onset AF was shown to double the risk of death 155 . Similar findings have been reported in different population settings 120, [156] [157] [158] . Multiple longitudinal studies have evaluated whether an interaction exists between sex and AF-related risk of death, but the results have not been consistent (see Supplementary information S10 (table)). Substantial differences in follow-up time pose a substantial challenge to direct comparison between the different studies. In the Framingham Heart Study 15 , investigators reported that with 40 years of follow-up, a significant interaction with sex existed, such that AF eliminated the survival advantage typically enjoyed by women. Data from the Copenhagen City Heart Study 120 , with mean follow-up of 4.7 years, reported a doubling of the risk of death in women with AF compared with men with AF. On the contrary, results from Olmsted County, Minnesota 155 , with mean follow-up of 5.3 years, and a post-hoc analy sis of the RE-LY trial 159 , with median follow-up of 2 years, have suggested that men with AF have a greater risk of death than women. In addition, several studiesincluding the Diet, Cancer, and Health cohort study in Denmark, with median follow-up of 4.9-5.1 yearshave reported that female sex is associated with reduced risk of death 128, 150, 160 . Adding to the inconsistency, multiple studies have not demonstrated male or female sex to be a significant risk factor for mortality in AF 35, [161] [162] [163] [164] [165] [166] . However, a meta-analysis of 19 studies showed increased risk of all-cause mortality in women compared with in men (RR 1.12, 95% CI 1.07-1.17) 167 . Notably, the meta-analysis included disease-based samples and the results might not be generalizable to the standard population. Nonetheless, the meta-analysis is consistent with previous reports suggesting that women with AF have a higher risk of death than men with AF.
Future directions
Compared with our understanding of sex-specific differences in coronary heart disease and stroke 168 , substantial gaps exist in our knowledge of sex-specific differences in AF (TABLE 1) . Well-powered, longitudinal studies to evaluate incidence, prevalence, risk factors, and prognosis of AF in women and men, as well as formal testing of sex as an effect modifier, are needed to establish whether the differences in the epidemiology and prognosis of AF are sex-dependent or whether they can be explained by confounding 33 . Although several studies have reported that risk factors for AF vary by sex, many of the studies had limited sample size, and did not formally test for effect modification by sex.
Another limitation of the AF epidemiological literature is the paucity of data from outside North America and Europe 1, 169 . Given that substantial racial and ethnic variations exist in population age distribution, they might be important confounders of the observed hetero geneity in the epidemiology and outcomes of AF between women and men. The AF-related sex-specific differences in epidemiology, risk factors, and outcomes identified in populations of European ancestry might not be generalizable to other ethnic groups.
Although the pathophysiology of AF has been investigated extensively over the years 170 , our understanding of the differences between male and female cardiac anatomy and electrical mechanisms, which might contribute to difference in risks and prognosis of AF by sex, is insufficient. Moreover, the contribution of the hormonal differences in women and men to risk and prognosis of AF should be evaluated more closely 95, 103, 171, 172 . Study of the genetics of AF has evolved rapidly, and considerable knowledge of genes and pathways associated with AF exists 6 . However, large-scale genetic association studies performed in women and men separately, and testing for sex interactions, are needed to identify potential genetic variants that have differential effects between the sexes or that are sex-specific. If such differences exist, the studies might help us to elucidate the molecular biology underlying differences in risk, effects of treatment, and prognosis related to AF in women and men, which in turn will aid development of personalized treatment and refinement of current risk-prediction models 173, 174 . Female sex has been extensively studied as a risk factor for AF-related stroke and thromboembolism, and most studies report an increased risk of stroke in women [116] [117] [118] [119] . Nonetheless, little is known of the underlying mech anisms. Studies evaluating potential biological causes -such as differences in prothrombotic state, cerebral blood flow, genetic predisposition, and sociocultural causes such as delayed medical care -might improve stroke prevention and treatment in women and men.
To date, little attention has been paid to potential sex-specific differences in the AF-related risks of HF, MI, and dementia. The increased risks of HF with preserved ejection fraction and non-ST-segment elevation MI in women with AF need to be validated in other populations. Additional studies with long-term follow-up will help to clarify the effect of AF on the risks of dementia and mortality, and potential sex-specific differences.
Conclusions
Evidence for sex-specific differences in the incidence, prevalence, population-attributable risks of major risk factors for AF, and in the clinical presentation and prognosis of patients with this arrhythmia is accumulating. Advancing our knowledge of the role of sex in the pathophysiology, symptoms, and complications of AF will help to provide new measures of prevention and treatment of AF to alleviate the public health burden.
